New! Sign up for our free email newsletter.

Psychedelic Drugs News

June 13, 2025

Top Headlines

 

As psychedelics gain traction as potential treatments for mental health disorders, an international study stands to improve the rigor and reliability of clinical ...
Snuff tubes uncovered at Chavin de Huantar in Peru reveal how leaders used mystical experiences to cement their ...
A new study suggests that fear and the immune system are connected in previously unknown ways. Researchers found that the immune system can influence stress and fear behaviors by changing how brain cells ...
Use of psilocybin, the hallucinogenic chemical found in what is known as 'magic mushrooms,' has increased significantly nationwide since 2019, according to a new ...
Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic ...
Researchers have achieved total chemical synthesis of the psychoactive compound ibogaine and its analogs from pyridine. The discovery will make it easier to explore the therapeutic possibilities of ...
One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health of cancer patients when accompanied by psychotherapy, a new study suggests. A second new study ...
Scholars for the first time identified chemical signatures of the components of a liquid concoction contained in a Bes mug. A new technique helped identify a sample flavored with honey, sesame seeds, pine nuts, licorice and grapes -- commonly used ...
New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics. The anti-anxiety andhallucination-inducing qualities of ...
A classic psychedelic, similar to LSD, psilocybin and mescalin, was found to activate a cell type in the brain that silences other neighboring neurons, a result that provides insight into how such drugs reduce anxiety, according to a new ...
A new tool to track the neurons and molecules activated in the brain by psychedlic drugs could help scientists unlock the benefits of psychedelic treatments for patients with brain ...
Researchers report that psilocybin, the active ingredient in magic mushrooms, destabilizes a critical network of brain areas involved in introspective thinking. The findings provide a neurobiological explanation for the drug's mind-bending ...

Latest Headlines

updated 12:17pm EDT

Earlier Headlines

 

Lifetime LSD use is associated with a higher likelihood of severe psychological distress after losing one's job, according to a new ...

Americans' interest in a potentially harmful 'magic mushroom' is soaring, according to a new study. The scientists suggest that the growing market for Amanita muscaria may be sparked ...

A study takes a closer look at the neurobiology of psychedelic experiences caused by nitrous oxide, ketamine and ...

Scientists have gleaned new insights into how psychedelics alter conscious experience via their action on brain ...

Location, location, location is the key for psychedelic drugs that could treat mental illness by rapidly rebuilding connections between nerve cells. Researchers show that engaging serotonin 2A ...

Researchers have discovered the active compound from an edible mushroom that boosts nerve growth and enhances ...

Researchers have participated in the largest and most rigorous clinical trial to date of psilocybin (a psychoactive ingredient in magic mushrooms), pointing to the possibility that COMP360 psilocybin ...

New research in animal models show it's possible to create a compound that hits the same exact target as psychedelic drugs hit -- the 5-HT2A serotonin receptors on the surface of specific ...

In a survey study of more than 3,000 adults, researchers compared psychedelic experiences with near-death experiences that were not drug related and found notable similarities in people's ...

Two doses of psilocybin, a compound found in psychedelic mushrooms, reduces heavy drinking by 83 percent on average among heavy drinkers when combined with psychotherapy, a new study ...

Marijuana and hallucinogen use in the past year reported by young adults 19 to 30 years old increased significantly in 2021 compared to five and 10 years ago, reaching historic highs in this age ...

Hallucinogen use has increased since 2015, overall and particularly among adults 26 and older, while use decreased in adolescents aged 12-17 years according to a new study. Estimates of over 5.5 ...

Researchers report that common genetic variations in one serotonin receptor could be a reason why people with psychiatric conditions, such as depression, respond differently to psychedelic ...